//
Aravind Ramakrishnan
Connie Lee Batlevi
Maria A V Marzolini
Wendy Osborne
Eleni Tholouli
Carlos Bachier
Peter A. McSweeney
Elizabeth Budde
Nancy L. Bartlett
Yiyun Zhang
Muhammad Al-Hajj
Martin Pule
Simon Thomas
Maud Jonnaert
Vijay G R Peddareddigari
Nushmia Z Khokhar
Robert Chen
Lazaros J. Lekakis
Sarah Cannon Blood Cancer Center at St. David's South Austin Medical Center, Austin, TX
Department of Urology, King's College Hospital NHS Foundation Trust, London, United Kingdom
Memorial Sloan Kettering Cancer Center, Port Washington, NY
Bart's Cancer Institute, London, United Kingdom
Department of Biochemistry, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
Department of Haematology, Leicester Royal Infirmary, Leicester, United Kingdom
Texas Transplant Institute, Nashville, TN
Colorado Blood Cancer Institute, Presbyterian/St. Luke's Medical Center, Denver, CO
Washington University School of Medicine and Siteman Cancer Center, St. Louis, MO
Autolus Therapeutics, London, NJ, United Kingdom
Dolon Ltd, London, United Kingdom
Autolus Therapeutics, Basel, Switzerland
Autolus Limited, London, United Kingdom
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
United States
United Kingdom
Switzerland
N/A
Oncology (ONC)
Diffuse large B-cell lymphoma
Coxsackie Virus And Adenovirus Receptor
Pembrolizumab
N/A
Cohort
I
N/A
N/A
N/A